Cargando…

Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae

BACKGROUND: Prompt administration of adequate empiric antimicrobial therapy is a major determinant influencing the outcome of serious infections. The objective of this study was to describe empiric antimicrobial therapy employed and assess its effect on the outcome of patients bacteremic with extend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaubey, Vikas P, Pitout, Johann DD, Dalton, Bruce, Ross, Terry, Church, Deirdre L, Gregson, Daniel B, Laupland, Kevin B
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877056/ https://www.ncbi.nlm.nih.gov/pubmed/20423493 http://dx.doi.org/10.1186/1756-0500-3-116

Ejemplares similares

Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, Calgary
por: Pitout, Johann D.D., et al.
Publicado: (2007)

Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region
por: Chaubey, Vikas P, et al.
Publicado: (2014)

Population-based laboratory surveillance of Hafnia alvei isolates in a large Canadian health region
por: Laupland, Kevin B, et al.
Publicado: (2006)

Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae
por: Pitout, Johann DD
Publicado: (2009)

Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
por: Peralta, Galo, et al.
Publicado: (2012)

Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producing Klebsiella pneumoniae Bacteremia in Cancer Patients
por: Nham, Eliel, et al.
Publicado: (2020)

Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020)

Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort
por: Thønnings, Sara, et al.
Publicado: (2019)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia
por: Namikawa, Hiroki, et al.
Publicado: (2023)

2175. Rapid Detection of Carbapenemase Producing Organisms Directly from Blood Cultures Positive for Gram-Negative Bacilli
por: Stokes, William, et al.
Publicado: (2019)

Phenotypic and genotypic detection of extended spectrum beta lactamase enzyme in Klebsiella pneumoniae
por: Mohammed, Aso Bakr, et al.
Publicado: (2022)

Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan
por: Komatsu, Yuko, et al.
Publicado: (2018)

Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital
por: Namikawa, Hiroki, et al.
Publicado: (2017)

Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative
por: Laupland, Kevin B, et al.
Publicado: (2009)

Blood cultures in ambulatory outpatients
por: Laupland, Kevin B, et al.
Publicado: (2005)

Validity of calendar day-based definitions for community-onset bloodstream infections
por: Laupland, Kevin B, et al.
Publicado: (2015)

Extended-Spectrum-Beta-Lactamases, AmpC Beta-Lactamases and Plasmid Mediated Quinolone Resistance in Klebsiella spp. from Companion Animals in Italy
por: Donati, Valentina, et al.
Publicado: (2014)

The Prevalence of TEM and SHV Genes among Extended-Spectrum Beta-Lactamases Producing Escherichia Coli and Klebsiella Pneumoniae
por: Zaniani, Fatemeh Riyahi, et al.
Publicado: (2012)

Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections
por: Bayraktar, Banu, et al.
Publicado: (2019)

211. Disease burden of bacteremia with extended-spectrum beta-lactamase-producing or carbapenem-resistant Enterobacteriaceae in Korea
por: Mi Lee, Chan, et al.
Publicado: (2023)

Instant Typing Is Essential to Detect Transmission of Extended-Spectrum Beta-Lactamase-Producing Klebsiella Species
por: Voor in 't holt, Anne F., et al.
Publicado: (2015)

Highlighting extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak by routine genomic typing
por: Gravey, F., et al.
Publicado: (2023)

An Evaluation of Vitek2™ Direct Susceptibility Testing (DST) of  Gram-Negative Bacteria (GNB) from Positive Blood Cultures (+BC).
por: Gregson, Daniel, et al.
Publicado: (2017)

Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study Across Karnataka
por: Rao, Sridhar PN, et al.
Publicado: (2014)

Bacteremia Caused by Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae in Vientiane, Lao PDR: A 5-Year Study
por: Chang, Ko, et al.
Publicado: (2020)

Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniae in patients on maintenance hemodialysis
por: Yang, Chih-Chao, et al.
Publicado: (2012)

Integron mediated multidrug resistance in extended spectrum beta-lactamase producing clinical isolates of Klebsiella pneumoniae
por: Mobarak-Qamsari, Maryam, et al.
Publicado: (2014)

A Rare Case of Pyonephrosis in an Infant Induced by Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
por: Alsowayan, Ossamah Saleh
Publicado: (2020)

Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia
por: Raouf, Faez Erees Abdul, et al.
Publicado: (2022)

Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
por: Coque, Teresa M., et al.
Publicado: (2008)

The distinct category of healthcare associated bloodstream infections
por: Lenz, Ryan, et al.
Publicado: (2012)

Clinical Outcome of Bacteremic Spontaneous Bacterial Peritonitis due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Pneumoniae
por: Kang, Cheol-In, et al.
Publicado: (2004)

Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection
por: Keshi, Lu, et al.
Publicado: (2019)

The effect of antibiotics and photodynamic therapy on extended-spectrum beta-lactamase (ESBL) positive of Escherichia coli and Klebsiella pneumoniae in urothelial cells
por: Al-Sarraj, Faisal
Publicado: (2021)

Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal
por: Nepal, Krishus, et al.
Publicado: (2017)

Intensive care unit-acquired urinary tract infections in a regional critical care system
por: Laupland, Kevin B, et al.
Publicado: (2005)

The Validation of a Novel Surveillance System for Monitoring Bloodstream Infections in the Calgary Zone
por: Leal, Jenine R., et al.
Publicado: (2016)

Frequency of Beta-Lactamase Antibiotic Resistance Genes in Escherichia Coli and Klebsiella pneumoniae
por: Golsha, Roghieh, et al.
Publicado: (2021)

128. Validation of a rapid diagnostics platform for detecting extended-spectrum beta-lactamase resistance in gram negative bacteremia
por: Andrews, Sam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_foedeac5p3sun3q6ampsjlfk1h